Pro-Dex Inc (NASDAQ:PDEX) Director Raymond E. Cabillot sold 6,000 shares of the stock in a transaction on Monday, November 19th. The stock was sold at an average price of $14.76, for a total transaction of $88,560.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Shares of PDEX opened at $14.20 on Tuesday. Pro-Dex Inc has a 12 month low of $6.05 and a 12 month high of $16.00. The firm has a market cap of $60.88 million and a P/E ratio of 27.17. The company has a quick ratio of 5.87, a current ratio of 7.44 and a debt-to-equity ratio of 0.25.
Pro-Dex (NASDAQ:PDEX) last announced its earnings results on Thursday, September 13th. The medical instruments supplier reported $0.03 EPS for the quarter. Pro-Dex had a net margin of 9.67% and a return on equity of 13.55%. The business had revenue of $6.25 million during the quarter.
Separately, ValuEngine upgraded shares of Pro-Dex from a “hold” rating to a “buy” rating in a report on Thursday, September 13th.
COPYRIGHT VIOLATION NOTICE: “Pro-Dex Inc (PDEX) Director Raymond E. Cabillot Sells 6,000 Shares” was first reported by WKRB News and is owned by of WKRB News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://www.wkrb13.com/2018/11/20/pro-dex-inc-pdex-director-raymond-e-cabillot-sells-6000-shares.html.
Pro-Dex Company Profile
Pro-Dex, Inc, together with its subsidiaries, designs, develops, and manufactures powered surgical instruments, dental instruments, and rotary air motors worldwide. It also manufactures plastic injection molds for various industries; and shavers and machined parts. In addition, it provides engineering, and quality and regulatory consulting services.
See Also: Earnings Per Share
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.